Sanne J. de Haart, Lisa Holthof, Willy A. Noort, Monique C. Minnema, Maarten E. Emmelot, Tineke Aarts-Riemens, Parul Doshi, Kate Sasser, Huipin Yuan, Joost de Bruijn, Anton C.M. Martens, Niels W.C.J van de Donk, Henk M. Lokhorst, Richard W.J. Groen, Tuna Mutis. Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance. haematol [Internet]. 2016Jul.31 [cited 2024Apr.28];101(8):e339-e342. Available from: https://haematologica.org/article/view/7808